It also showed that the mutation in palmitoylation site reduced the ability of human tetraspanin CD81 to interact with other proteins (Delandre et al., 2009) and tetraspanin CD82 to inhibit cancer cell migration and invasion (Zhou et al., 2004). Here, CD82 is linked to cancer.